Joy Burchell spends much of her time researching Molecular biology, Glycosylation, Antibody, Mucin and Epitope. Her Molecular biology research integrates issues from Tandem repeat, Complementary DNA, MUC1, Monoclonal antibody and Peptide. Her work investigates the relationship between Glycosylation and topics such as Glycoprotein that intersect with problems in Chinese hamster ovary cell, Immunohistochemistry and Staining.
Her Mucin study is concerned with the field of Biochemistry as a whole. Her Epitope study incorporates themes from Peptide sequence and Glycosyltransferase. The study incorporates disciplines such as Cancer, Breast cancer cell line and Surgical oncology in addition to Antigen.
Her primary areas of study are Molecular biology, MUC1, Mucin, Antibody and Antigen. Her studies in Molecular biology integrate themes in fields like Complementary DNA, Glycosylation, Monoclonal antibody and Tandem repeat. Her research in MUC1 intersects with topics in Cell culture, Cancer research, Chimeric antigen receptor and Cell biology.
As part of one scientific family, Joy Burchell deals mainly with the area of Mucin, narrowing it down to issues related to the Epitope, and often Peptide sequence. Her work on Autoantibody as part of general Antibody study is frequently linked to Glycopeptide, bridging the gap between disciplines. Her Antigen research includes themes of Cytotoxic T cell, Immunogen, Immune system and Cancer immunotherapy.
Her scientific interests lie mostly in Cancer research, Cancer, MUC1, Mucin and Cell biology. Her biological study spans a wide range of topics, including Immune checkpoint, Tumor progression and Immune system. Her work on Cancer immunotherapy as part of general Cancer research is frequently linked to H3k4 methylation, bridging the gap between disciplines.
Her research links Fibrosis with MUC1. She has included themes like Stroma, Phagocytosis, Phenotype, Transcriptome and Macrophage in her Mucin study. Her study on Cell biology also encompasses disciplines like
Her primary scientific interests are in Cancer research, Cancer, Immune system, Breast cancer and Nuclear protein. Her Cancer research study typically links adjacent topics like Glycosylation. Her study in Cancer is interdisciplinary in nature, drawing from both Therapeutic strategy, Intensive care medicine and Immune effector.
Her Immune system study combines topics from a wide range of disciplines, such as Myeloid and Chemotherapy. The Breast cancer study combines topics in areas such as Receptor, Glycosyltransferase, Endoplasmic reticulum, Glycan and Selectin. Joy Burchell combines subjects such as Repressor and Histone Demethylases with her study of Nuclear protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular cloning and expression of human Tumor-associated Polymorphic Epithelial Mucin
S.J. Gendler;C.A. Lancaster;J. Taylor-Papadimitriou;T. Duhig.
Journal of Biological Chemistry (1990)
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.
Joyce Taylor-Papadimitriou;J. A. Peterson;J. Arklie;Joy Burchell.
International Journal of Cancer (1981)
A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.
Sandra Gendler;Joyce Taylor-Papadimitriou;Trevor Duhig;Jonathan Rothbard.
Journal of Biological Chemistry (1988)
Development and Characterization of Breast Cancer Reactive Monoclonal Antibodies Directed to the Core Protein of the Human Milk Mucin
Joy Burchell;Sandra Gendler;Joyce Taylor-Papadimitriou;Anne Girling.
Cancer Research (1987)
MUC1 and cancer
J Taylor-Papadimitriou;J Burchell;D.W Miles;M Dalziel.
Biochimica et Biophysica Acta (1999)
Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: DEMONSTRATION OF SIMPLER AND FEWER GLYCAN CHAINS IN TUMOR CELLS
Kenneth O. Lloyd;Joy Burchell;Valery Kudryashov;Beatrice W.T. Yin.
Journal of Biological Chemistry (1996)
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Suzanne A. Eccles;Eric O. Aboagye;Simak Ali;Annie S. Anderson.
Breast Cancer Research (2013)
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.
Anne Girling;Jirina Bartkova;Joy Burchell;Sandra Gendler.
International Journal of Cancer (1989)
Mechanisms Underlying Aberrant Glycosylation of MUC1 Mucin in Breast Cancer Cells
Inka Brockhausen;Ji‐Mao Yang;Joy Burchell;Caroline Whitehouse.
FEBS Journal (1995)
Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells.
J Burchell;H Durbin;J Taylor-Papadimitriou.
Journal of Immunology (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
University of Copenhagen
University of Copenhagen
University of Porto
Mayo Clinic
Novo Nordisk (Denmark)
King's College London
King's College London
University of Nebraska Medical Center
The Francis Crick Institute
Shanghai University of Electric Power
University of Paris-Saclay
Delft University of Technology
University of Melbourne
Universidade Federal de Viçosa
Albert Einstein College of Medicine
Simon Fraser University
University of Bari Aldo Moro
The Ohio State University
École Polytechnique Fédérale de Lausanne
Leipzig University
Umeå University
Brigham and Women's Hospital
Danish Institute for International Studies
McGill University
University of Arizona